Peregrine Investment Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-68,220
Closed -$11.3M 24
2025
Q4
$11.3M Sell
68,220
-28,850
-30% -$4.83M 7.05% 2
2025
Q3
$19M Sell
97,070
-48,970
-34% -$8.05M 9.34% 1
2025
Q2
$13.2M Sell
146,040
-3,960
-3% -$313K 8.44% 2
2025
Q1
$8.95M Buy
150,000
+69,210
+86% +$6.4M 6.68% 3
2024
Q4
$10.7M Buy
+80,790
New +$7.58M 6.21% 1

Other funds holding ALAB

Peregrine Investment Management's ALAB Position: Q1 2026 in Review

Peregrine Investment Management sold out of Astera Labs (ALAB) in Q1 2026, closing a stake of 68,220 shares — an estimated $11.3M sold.

Peregrine Investment Management first reported a position in ALAB in Q4 2024 and held it in 5 quarters. The position peaked at $19M in Q3 2025. 708 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Peregrine Investment Management reported no remaining Astera Labs position as of Q1 2026 after selling out during the quarter.
  • Peregrine Investment Management sold 68,220 Astera Labs shares in Q1 2026, an estimated $11.3M.
  • Peregrine Investment Management first reported a position in Astera Labs in Q4 2024 and held it in 5 quarters.
  • Peregrine Investment Management's Astera Labs position peaked at $19M in Q3 2025.
  • 708 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Peregrine Investment Management's 13F filing for Q1 2026, filed 15 Apr 2026.